Viewing Study NCT02385058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-06-25 @ 1:16 AM
Study NCT ID: NCT02385058
Status: COMPLETED
Last Update Posted: 2015-04-14
First Post: 2015-03-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population
Sponsor: Janssen-Cilag Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Helminthiasis View
None Amoebiasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Helminthiasis View
None Amoebiasis View
None Mebendazole View
None Quinfamide View
None Mexican population View